Long-term follow-up of nasal immunetherapy to Parietaria: Clinical and local immunological effects

Clinical and Experimental Allergy

Volumn 27, Issue 8, 1997, Pages 904-908

  Passalacqua, G ^a   Albano, M ^a   Pronzato, C ^a   Riccio, A M ^a   Scordamaglia, A ^a   Falagiani, P ^b   Canonica, G W ^a,c  

^a UNIVERSITY OF GENOA   (Italy)

^b Lofarma SpA   (Italy)

^c Allerg and Clin Immunology Service   (Italy)

Author keywords

Allergic inflammation; Local nasal immunotherapy; Specific nasal provocation test

Indexed keywords

ADULT; ALLERGY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; IMMUNOTHERAPY; MALE; POLLEN; POLLEN ALLERGY; PRIORITY JOURNAL; SEASONAL VARIATION; TREATMENT OUTCOME;

ADMINISTRATION, INTRANASAL; ADULT; ALLERGENS; DESENSITIZATION, IMMUNOLOGIC; DOUBLE-BLIND METHOD; EOSINOPHILS; EPITHELIUM; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOTHERAPY; INTERCELLULAR ADHESION MOLECULE-1; LEUKOCYTE COUNT; MALE; NASAL PROVOCATION TESTS; NEUTROPHILS; PLACEBOS; PLANTS; POLLEN; RHINITIS, ALLERGIC, PERENNIAL; SEASONS; TIME FACTORS;

EID: 0030742511     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.1997.tb01231.x     Document Type: Article

References (19)

1. Immunotherapy position paper. Malling HJ, Wecke B edts. Allergy 1993; 48 (supp): 1-81.
2. Johansson SGO, Deutsche H, Zetterstomm O. Use of glutaraldehyde-modified timothy grass pollen extract in nasal hyposensitization of hay fever. Int Archs Allergy Appl Immunol 1979; 60:447-60.
3. Schumaker MJ, Pain MCF. Intranasal immunotherapy with polymerized grass pollen allergens. Allergy 1981; 37:241-5.
4. Nickelsen JA, Goldstein S, Muller U et al. Local intranasal immunothrapy for ragweed allergic rhinitis: clinical response. J Allergy Clin Immunol 1981; 68:33-40.
5. Welsh PW, Butterfield JH, Yunginger W, Agarwahl MK, Gleich GJ. Allergen controlled study of intranasal immunotherapy for ragweed hay fever. Allergy Clin Immunol 1983; 71:454-60.
6. Georgitis JW, Reisman RE, Clayton WF et al. Local nasal immunotherapy for grass allergic rhinitis. J Allergy Clin Immunol 1983; 71:71-6.
7. Andri L, Senna GE, Betteli G et al. Local nasal immunotherapy for dermatophagoides- induced rhinitis: efficacy of a powder extract. J Allergy Clin Immunology 1993; 91:587-96.
8. Andri L, Senna GE, Betteli C et al. Local nasal immunotherapy in allergic rhinitis to Parietaria. Allergy 1992; 47: 318-23.
9. D'Amato G, Lobefalo G, Liccardi G, Cazzola M. A double blind placebo controlled trial of local nasal immunotherapy in allergic rhinitis to parietaria pollen. Clin Exp Allergy 1995; 25:141-8.
10. Gasparini A, Di Franco G, Malavenda A. Preliminary evaluation of the nasal local specific immunotherapy in mites-sensitive respiratory patients. Persp ENT Immunol 1992; 5:29-33.
11. Ariano R, Panzani RC, Chiapella M, Augeri G, Falagiani P. Local immunotherapy of seasonal allergic rhinitis in children due to parietaria pollen: a preliminary report. Pediatr Asthma Allergy Immunol 1993; 7:227-237.
12. Passalacqua G, Albano M, Ruffoni S, Pronzato C et al. Local nasal immunotherapy to parietaria: evidence of reduction of allergic inflammation. Am J Respir Crit Care Med 1995; 152:461-466.
13. Andri L, Senna GE, Andri G et al. Local nasal immunotherapy for birch allergic rhinitis with extract in powder form. Clin Exp Allergy 1995; 25:1092-1099.
14. Naclerio R. Local nasal immunotherapy. Has the time come? Am J Resp Crit Care Med 1995; 152:425-426.
15. Des Roches A, Paradis L, Kanani J et al. Immunotherapy with a standardized Dermatophagoides Pteronyssinus extract. V. Duration of the effectiveness of immunotherapy after its cessation. Allergy 1996; 51:430-433.
16. Hedlin G, Heilborn H, Lilja G et al. Long term follow up of patients treated with a three year course of cat and dog immunotherapy. J Allergy Clin Immunol 1995; 96:879-895.
17. Ciprandi G, Pronzato C, Ricca V et al. Allergen specific challenge induces intercellular adhesion molecule-1 (ICAM-1 or CD54) on nasal epithelial cells in allergic subjects: relationship with early and late phase inflammatory phenomena. Am J Respir Crit Care Med 1995; 150:1653-1659.
18. Cordell JL, Falini B, Erber WN et al. Immunoenzimatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti alkaline phosphatase (APAAP complexes). J Histochem Cytochem 1984; 32:219-245.
19. Passalacqua G, Canonica GW. Alternative routes for specific immunotherapy. J Invest Allergol Clin Immunol 1996; 6:81-87.